Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase γ inhibitor for the treatment of inflammatory diseases

Yusuke Oka, Tetsuya Yabuuchi, Takahiro Oi, Shoichi Kuroda, Yasuyuki Fujii, Hidenori Ohtake, Tomoyuki Inoue, Shunichi Wakahara, Kayo Kimura, Kiyoko Fujita,

Bioorganic & Medicinal Chemistry · 2013 · 21 citations · 9 references

DOIFull text

Open access

Concepts

References

9